Evidence verdict: Research in people with frailty offers reasons to investigate MSC therapy. It does not justify promising that an umbilical cord MSC infusion will restore energy, improve sleep, prevent infections, or reverse aging in a general wellness patient.
Feeling better matters. The harder question is whether a specific treatment caused that improvement and whether another patient can reasonably expect the same result. Those questions deserve more than an appealing biological explanation.
What a human trial actually measured
A 2017 randomized, blinded, placebo-controlled study enrolled 30 people with frailty. It compared intravenous donor MSCs at two doses with placebo. Its primary endpoint was serious treatment-emergent adverse events at one month; functional and immune measures were secondary endpoints. Some measures improved within the 100-million-cell group. That is an encouraging early signal, but significance within one group is not automatically evidence of superiority over placebo. The authors called for larger trials. Tompkins et al., 2017.
This study does not establish a wellness protocol for a different population, product or route. It also cannot supply a general recommendation about how many cells a person should purchase.
Four claims that need separate evidence
- Energy: A change in a walking test is not interchangeable with relief of unexplained fatigue.
- Immunity: A change in an immune marker does not by itself demonstrate fewer infections.
- Sexual health: A questionnaire signal does not establish a general treatment for low libido or erectile dysfunction.
- Sleep: A hypothesis about inflammation is not a controlled human sleep-treatment result.
These are distinctions between outcomes, not reasons to dismiss future research. Each claim needs a study that actually tests it.
How to interpret a testimonial
A patient may sincerely report greater energy after treatment. Their experience should be heard without converting it into an efficacy estimate. To evaluate causation, we also need comparison groups, other treatments, the measurement method, duration of follow-up, and the experiences of patients who did not improve.
Before paying for a wellness infusion
Ask the provider to identify the exact product and the human trial supporting your intended outcome. Ask what the study did not demonstrate, what the risks and alternatives are, and what happens if there is no benefit. Seek an assessment of persistent symptoms rather than assuming that aging is the diagnosis.
Supporting legitimate regenerative medicine includes refusing to promise a benefit the evidence has not established.
Disclosure: Dr. Ramon De La Puerta is affiliated with Z-Lounge Regenerative Medicine and has a commercial interest in regenerative-medicine services. This relationship should be considered when reading this article. The discussion is educational and does not determine whether a treatment is appropriate for an individual patient.
Correction — September 11, 2026: This revision removes a bibliography entry described in the previous version as a hypothetical, unpublished sleep study. It also removes unsupported rejuvenation promises and testimonial percentages presented without an adequate evidence context.
